2023-02-012024-01-312024-01-31false09187218FALLOUH HEALTHCARE LIMITED2024-09-1574909iso4217:GBPxbrli:pure091872182023-02-01091872182024-01-31091872182023-02-012024-01-31091872182022-02-01091872182023-01-31091872182022-02-012023-01-3109187218bus:SmallEntities2023-02-012024-01-3109187218bus:AuditExempt-NoAccountantsReport2023-02-012024-01-3109187218bus:FullAccounts2023-02-012024-01-3109187218bus:PrivateLimitedCompanyLtd2023-02-012024-01-3109187218core:WithinOneYear2024-01-3109187218core:AfterOneYear2024-01-3109187218core:WithinOneYear2023-01-3109187218core:AfterOneYear2023-01-3109187218core:ShareCapital2024-01-3109187218core:SharePremium2024-01-3109187218core:RevaluationReserve2024-01-3109187218core:OtherReservesSubtotal2024-01-3109187218core:RetainedEarningsAccumulatedLosses2024-01-3109187218core:ShareCapital2023-01-3109187218core:SharePremium2023-01-3109187218core:RevaluationReserve2023-01-3109187218core:OtherReservesSubtotal2023-01-3109187218core:RetainedEarningsAccumulatedLosses2023-01-3109187218core:LandBuildings2024-01-3109187218core:PlantMachinery2024-01-3109187218core:Vehicles2024-01-3109187218core:FurnitureFittings2024-01-3109187218core:OfficeEquipment2024-01-3109187218core:NetGoodwill2024-01-3109187218core:IntangibleAssetsOtherThanGoodwill2024-01-3109187218core:ListedExchangeTraded2024-01-3109187218core:UnlistedNon-exchangeTraded2024-01-3109187218core:LandBuildings2023-01-3109187218core:PlantMachinery2023-01-3109187218core:Vehicles2023-01-3109187218core:FurnitureFittings2023-01-3109187218core:OfficeEquipment2023-01-3109187218core:NetGoodwill2023-01-3109187218core:IntangibleAssetsOtherThanGoodwill2023-01-3109187218core:ListedExchangeTraded2023-01-3109187218core:UnlistedNon-exchangeTraded2023-01-3109187218core:LandBuildings2023-02-012024-01-3109187218core:PlantMachinery2023-02-012024-01-3109187218core:Vehicles2023-02-012024-01-3109187218core:FurnitureFittings2023-02-012024-01-3109187218core:OfficeEquipment2023-02-012024-01-3109187218core:NetGoodwill2023-02-012024-01-3109187218core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3109187218core:ListedExchangeTraded2023-02-012024-01-3109187218core:UnlistedNon-exchangeTraded2023-02-012024-01-3109187218core:MoreThanFiveYears2023-02-012024-01-3109187218core:Non-currentFinancialInstruments2024-01-3109187218core:Non-currentFinancialInstruments2023-01-3109187218dpl:CostSales2023-02-012024-01-3109187218dpl:DistributionCosts2023-02-012024-01-3109187218core:LandBuildings2023-02-012024-01-3109187218core:PlantMachinery2023-02-012024-01-3109187218core:Vehicles2023-02-012024-01-3109187218core:FurnitureFittings2023-02-012024-01-3109187218core:OfficeEquipment2023-02-012024-01-3109187218dpl:AdministrativeExpenses2023-02-012024-01-3109187218core:NetGoodwill2023-02-012024-01-3109187218core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3109187218dpl:GroupUndertakings2023-02-012024-01-3109187218dpl:ParticipatingInterests2023-02-012024-01-3109187218dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-012024-01-3109187218core:ListedExchangeTraded2023-02-012024-01-3109187218dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-012024-01-3109187218core:UnlistedNon-exchangeTraded2023-02-012024-01-3109187218dpl:CostSales2022-02-012023-01-3109187218dpl:DistributionCosts2022-02-012023-01-3109187218core:LandBuildings2022-02-012023-01-3109187218core:PlantMachinery2022-02-012023-01-3109187218core:Vehicles2022-02-012023-01-3109187218core:FurnitureFittings2022-02-012023-01-3109187218core:OfficeEquipment2022-02-012023-01-3109187218dpl:AdministrativeExpenses2022-02-012023-01-3109187218core:NetGoodwill2022-02-012023-01-3109187218core:IntangibleAssetsOtherThanGoodwill2022-02-012023-01-3109187218dpl:GroupUndertakings2022-02-012023-01-3109187218dpl:ParticipatingInterests2022-02-012023-01-3109187218dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-012023-01-3109187218core:ListedExchangeTraded2022-02-012023-01-3109187218dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-012023-01-3109187218core:UnlistedNon-exchangeTraded2022-02-012023-01-3109187218core:NetGoodwill2024-01-3109187218core:IntangibleAssetsOtherThanGoodwill2024-01-3109187218core:LandBuildings2024-01-3109187218core:PlantMachinery2024-01-3109187218core:Vehicles2024-01-3109187218core:FurnitureFittings2024-01-3109187218core:OfficeEquipment2024-01-3109187218core:AfterOneYear2024-01-3109187218core:WithinOneYear2024-01-3109187218core:ListedExchangeTraded2024-01-3109187218core:UnlistedNon-exchangeTraded2024-01-3109187218core:ShareCapital2024-01-3109187218core:SharePremium2024-01-3109187218core:RevaluationReserve2024-01-3109187218core:OtherReservesSubtotal2024-01-3109187218core:RetainedEarningsAccumulatedLosses2024-01-3109187218core:NetGoodwill2023-01-3109187218core:IntangibleAssetsOtherThanGoodwill2023-01-3109187218core:LandBuildings2023-01-3109187218core:PlantMachinery2023-01-3109187218core:Vehicles2023-01-3109187218core:FurnitureFittings2023-01-3109187218core:OfficeEquipment2023-01-3109187218core:AfterOneYear2023-01-3109187218core:WithinOneYear2023-01-3109187218core:ListedExchangeTraded2023-01-3109187218core:UnlistedNon-exchangeTraded2023-01-3109187218core:ShareCapital2023-01-3109187218core:SharePremium2023-01-3109187218core:RevaluationReserve2023-01-3109187218core:OtherReservesSubtotal2023-01-3109187218core:RetainedEarningsAccumulatedLosses2023-01-3109187218core:NetGoodwill2022-02-0109187218core:IntangibleAssetsOtherThanGoodwill2022-02-0109187218core:LandBuildings2022-02-0109187218core:PlantMachinery2022-02-0109187218core:Vehicles2022-02-0109187218core:FurnitureFittings2022-02-0109187218core:OfficeEquipment2022-02-0109187218core:AfterOneYear2022-02-0109187218core:WithinOneYear2022-02-0109187218core:ListedExchangeTraded2022-02-0109187218core:UnlistedNon-exchangeTraded2022-02-0109187218core:ShareCapital2022-02-0109187218core:SharePremium2022-02-0109187218core:RevaluationReserve2022-02-0109187218core:OtherReservesSubtotal2022-02-0109187218core:RetainedEarningsAccumulatedLosses2022-02-0109187218core:AfterOneYear2023-02-012024-01-3109187218core:WithinOneYear2023-02-012024-01-3109187218core:Non-currentFinancialInstrumentscore:CostValuation2023-02-012024-01-3109187218core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-012024-01-3109187218core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-012024-01-3109187218core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-012024-01-3109187218core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-012024-01-3109187218core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-012024-01-3109187218core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3109187218core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3109187218core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3109187218core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3109187218core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3109187218core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3109187218core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3109187218core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3109187218core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3109187218core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3109187218core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3109187218core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3109187218core:Non-currentFinancialInstrumentscore:CostValuation2023-01-3109187218core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-3109187218core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-3109187218core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-3109187218core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-3109187218core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-3109187218core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-3109187218core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-3109187218core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-3109187218bus:Director12023-02-012024-01-3109187218bus:Director22023-02-012024-01-3109187218bus:Director32023-02-012024-01-31

FALLOUH HEALTHCARE LIMITED

Registered Number
09187218
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2024

FALLOUH HEALTHCARE LIMITED
Company Information
for the year from 1 February 2023 to 31 January 2024

Directors

FALLOUH, Adib
FALLOUH, Hazem, Dr
SALVARY, Venicia Judith, Dr

Registered Address

151 Castlehill Road
Walsall
WS9 9DB

Registered Number

09187218 (England and Wales)
FALLOUH HEALTHCARE LIMITED
Balance Sheet as at
31 January 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets325,63426,699
25,63426,699
Current assets
Debtors4296,563451,387
Cash at bank and on hand5,12350,932
301,686502,319
Creditors amounts falling due within one year5(81,756)(165,829)
Net current assets (liabilities)219,930336,490
Total assets less current liabilities245,564363,189
Creditors amounts falling due after one year6(36,384)(42,617)
Net assets209,180320,572
Capital and reserves
Called up share capital100100
Profit and loss account209,080320,472
Shareholders' funds209,180320,572
The financial statements were approved and authorised for issue by the Board of Directors on 15 September 2024, and are signed on its behalf by:
FALLOUH, Hazem, Dr
Director
Registered Company No. 09187218
FALLOUH HEALTHCARE LIMITED
Notes to the Financial Statements
for the year ended 31 January 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings25
Vehicles25
Office Equipment25
2.Average number of employees

20242023
Average number of employees during the year21
3.Tangible fixed assets

Vehicles

Office Equipment

Total

£££
Cost or valuation
At 01 February 2393,85110,996104,847
Additions-8,4868,486
At 31 January 2493,85119,482113,333
Depreciation and impairment
At 01 February 2374,0534,09578,148
Charge for year6,6002,9519,551
At 31 January 2480,6537,04687,699
Net book value
At 31 January 2413,19812,43625,634
At 31 January 2319,7986,90126,699
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables246,600426,000
Other debtors31,36017,222
Prepayments and accrued income18,6038,165
Total296,563451,387
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables7,5545,442
Bank borrowings and overdrafts16,16319,418
Taxation and social security56,983139,864
Other creditors1,0561,105
Total81,756165,829
6.Creditors: amounts due after one year

2024

2023

££
Other creditors36,38442,617
Total36,38442,617
7.Obligations under finance leases

2024

2023

££
Finance lease and HP contracts36,38442,617